Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study.

Hsu MC, Lee KT, Hsiao WC, Wu CH, Sun HY, Lin IL, Young KC.

BMC Cancer. 2013 Jul 5;13:330. doi: 10.1186/1471-2407-13-330.

2.

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.

Wu Y, Yu Y, Zhao T, Wang S, Fu Y, Qi Y, Yang G, Yao W, Su Y, Ma Y, Shi J, Jiang J, Kou C.

PLoS One. 2016 Jan 29;11(1):e0147946. doi: 10.1371/journal.pone.0147946. eCollection 2016.

3.

APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.

Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, Lin SW, Wu JH, Kao JT.

Clin Chim Acta. 2008 Apr;390(1-2):56-62. doi: 10.1016/j.cca.2007.12.014. Epub 2007 Dec 27.

PMID:
18206649
4.

Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.

Ding Y, Zhu MA, Wang ZX, Zhu J, Feng JB, Li DS.

J Biomed Biotechnol. 2012;2012:509420. doi: 10.1155/2012/509420. Epub 2012 May 23.

5.

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Yin RX, Li YY, Lai CQ.

Lipids Health Dis. 2011 Aug 19;10:140. doi: 10.1186/1476-511X-10-140.

6.

Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.

Liu Y, Ordovas JM, Gao G, Province M, Straka RJ, Tsai MY, Lai CQ, Zhang K, Borecki I, Hixson JE, Allison DB, Arnett DK.

Pharmacogenet Genomics. 2009 Feb;19(2):161-9. doi: 10.1097/FPC.0b013e32831e030e.

7.

Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.

Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J, Parnell LD, Garcia-Rios A, Ordovas JM, Lopez-Miranda J.

J Lipid Res. 2010 Jan;51(1):63-73. doi: 10.1194/jlr.M800527-JLR200.

8.

Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease.

Shanker J, Perumal G, Rao VS, Khadrinarasimhiah NB, John S, Hebbagodi S, Mukherjee M, Kakkar VV.

Lipids Health Dis. 2008 Sep 19;7:33. doi: 10.1186/1476-511X-7-33.

9.

Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.

Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B.

Atherosclerosis. 2010 Feb;208(2):427-32. doi: 10.1016/j.atherosclerosis.2009.08.013. Epub 2009 Aug 15.

PMID:
19732897
10.

Association of APOA1 gene polymorphisms (rs670, rs5069, and rs2070665) with dyslipidemia in the Kazakhs of Xinjiang.

Feng DW, Ma RL, Guo H, He J, Yan YZ, Muratbek, Niu Q, Li SG, Rui DS, Sun F, Zhang M, Zhang JY, Ding YS, Liu JM, Wang K, Guo SX.

Genet Mol Res. 2016 Apr 27;15(2). doi: 10.4238/gmr.15028094.

11.

Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels.

Yin RX, Li YY, Wu JZ, Pan SL, Liu CW, Lin WX, Yang DZ.

Alcohol Clin Exp Res. 2013 Feb;37(2):234-43. doi: 10.1111/j.1530-0277.2012.01918.x. Epub 2012 Aug 24.

PMID:
22924697
12.

Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change.

Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R.

Clin Chem Lab Med. 2007;45(3):316-20.

PMID:
17378725
13.

Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer.

Hamrita B, Ben Nasr H, Gabbouj S, Bouaouina N, Chouchane L, Chahed K.

Mol Biol Rep. 2011 Mar;38(3):1637-43. doi: 10.1007/s11033-010-0274-0. Epub 2010 Sep 15.

PMID:
20842444
14.

The association between apolipoprotein A1-C3-A5 gene cluster promoter polymorphisms and risk of ischemic stroke in the northern Chinese Han population.

Wang Y, Liu F, Li L, Deng S, He Z.

J Int Med Res. 2017 Dec;45(6):2042-2052. doi: 10.1177/0300060517713517. Epub 2017 Jun 21.

15.

Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study.

Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mehrabi Y, Hedayati M, Soheilian-Khorzoghi M, Azizi F.

Br J Nutr. 2015 Feb 28;113(4):644-53. doi: 10.1017/S0007114514003687. Epub 2015 Feb 5.

PMID:
25653052
16.

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.

Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinga-Thie G, Krauss RM, Sinsheimer JS, Cantor RM, de Bruin TW, Lusis AJ.

Circ Res. 2004 Apr 16;94(7):993-9. Epub 2004 Mar 4.

17.

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.

Swanson CR, Li K, Unger TL, Gallagher MD, Van Deerlin VM, Agarwal P, Leverenz J, Roberts J, Samii A, Gross RG, Hurtig H, Rick J, Weintraub D, Trojanowski JQ, Zabetian C, Chen-Plotkin AS.

Mov Disord. 2015 May;30(6):805-12. doi: 10.1002/mds.26022. Epub 2014 Sep 16.

18.

Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demethylating agents on intestinal cells.

Guardiola M, Oliva I, Guillaumet A, Martín-Trujillo Á, Rosales R, Vallvé JC, Sabench F, Del Castillo D, Zaina S, Monk D, Ribalta J.

Atherosclerosis. 2014 Dec;237(2):528-35. doi: 10.1016/j.atherosclerosis.2014.10.029. Epub 2014 Oct 22.

PMID:
25463085
19.

The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.

Korobeinikova E, Myrzaliyeva D, Ugenskiene R, Raulinaityte D, Gedminaite J, Smigelskas K, Juozaityte E.

BMC Genet. 2015 Jun 26;16:70. doi: 10.1186/s12863-015-0234-8.

20.

Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk.

Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, Lairon D, Planells R, Roche HM.

Atherosclerosis. 2011 Feb;214(2):408-14. doi: 10.1016/j.atherosclerosis.2010.10.029. Epub 2010 Nov 3.

PMID:
21122859

Supplemental Content

Support Center